Community Center
May 28, 2026
From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart failure care in ATTR-CM.
Relevant…
May 28, 2026
Intellia said the FDA lifted the clinical hold on its heart-disease gene-editing trial for transthyretin amyloidosis, a rare condition caused by buildup of a faulty…
May 27, 2026
Attruby Emerges as a Compelling Alternative to Vyndamax in Cardiac Amyloidosis Treatment. Read now at PatientWorthy.com#PatientWorthy #VYNDAMAX #ATTR-COM #…
May 25, 2026
Hi, could I ask those with cardiac involvement, when did your cardiac symptoms first start please? Thank you
May 25, 2026
We invite you to join us for our upcoming webinar, he Cardiac AL Amyloidosis Bridge: Connecting Patient Stories to Expert Care❗️Together, our panel, Dr Ahmad Masri…
May 22, 2026
In this video, Dr. Timothy Welch, cardiologist at Virginia Heart, discusses amyloidosis, what it is, how it affects the body, and current approaches to diagnosis…
May 21, 2026
AL Amyloidosis is a rare and often misunderstood disease that can silently affect multiple organs, making diagnosis extremely challenging. In this insightful…
May 21, 2026
My Dad is his newly diagnosed cardiac amyloidosis.Grade 3 Attr Cardio hisPMH includes asthma, essential hypertension, chronic diastolic heart failure,…
May 19, 2026
Ever heard of ATTR-cardiac amyloidosis (ATTR-CM)?Most people haven't — and that's part of the problem. ATTR-CM is a disease of the heart muscle caused by a…